Drug
Srp 6004
Srp 6004: highest development phase Phase 1, developed by Sarepta Therapeutics. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Sarepta Therapeutics
Trials
| Drug | Phase | Indication |
|---|---|---|
| SRP-6004 NCT05906251 | Phase 1 | Limb Girdle Muscular Dystrophy |
Latest
No recent events.
Follow Srp 6004 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.